China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Development and validation of a risk model for severe postpartum hemorrhage associated with placenta accreta'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129899
Registration Time: 2026/08/11
Type: Observational study
Primary Sponsor: Fujian Maternity and Child Health Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=311629
Published by HT Digital Content Services with permission from Health Daily Digest....